Sec. 3. Public health promotion and prevention
471 words·~2 min read·
/bill/118/s/4246/is/section-3·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Title III of the Public Health Service Act ( 42 U.S.C. 241 et seq. ) is amended by adding at the end the following: The Secretary shall expand public health promotion and prevention activities with respect to mid-life women’s health and chronic conditions, including diabetes, hypertension, heart disease, iron-deficiency anemia, inflammation, fibroids, endometriosis, and other related conditions and adverse health outcomes, at the discretion of the Secretary. The Secretary shall award grants to eligible entities to improve the early detection, diagnosis, and treatment of perimenopause and menopausal symptoms and support public health activities to expand access to quality care services and improve mid-life health outcomes among women.
To be eligible to receive a grant under paragraph (1), an entity shall― be— a State, local, Tribal, or territorial public health department; an accredited entity that offers education to students in various health professions; or such other type of entity, as the Secretary determines appropriate; and submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require. The Secretary shall award grants to eligible entities described in subsection (b)(2) to support care coordination and care planning activities, including such activities otherwise supported under this Act, and expand access to quality primary care and specialty care services to improve— mid-life women’s health, including activities to support the integration of primary care and specialty care; bone health and muscle loss; mental and behavioral health care services; joint, nerve, and muscle pain prevention services; digestive and metabolic health; prevention and management of multiple chronic conditions; physical therapy and injury prevention support services for populations affected by acute and chronic menopausal symptoms; and other services that address acute and chronic conditions that affect women’s health in perimenopause and menopause.
The Secretary shall develop recommendations and best practices to— increase access to mental and behavioral health care services and substance use disorder prevention services for women experiencing perimenopause or menopausal symptoms; and expand substance use disorder treatment, recovery, and support services for women experiencing perimenopause, early menopause, premature menopause, and related conditions. The Secretary shall develop recommendations and best practices for— reducing disparities in the management of menopausal symptoms; improving access to perimenopause and menopause health care services; and providing patient-centered perimenopause and menopause counseling and treatment.
The Secretary shall carry out and support— outreach and engagement activities of the Food and Drug Administration with health care providers on perimenopause and menopause and mid-life women’s health; oversight efforts to assess the safety and effectiveness of new diagnostic tools for perimenopause or menopausal symptoms, including devices that use artificial intelligence; and support existing activities of the Department of Health and Human Services to enforce privacy protections for patients.
To carry out this section, there are authorized to be appropriated $10,000,000 for each of fiscal years 2025 through 2029. .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 3
Public health promotion and prevention
Cites 1Cited by 0 across 0 sources